| Year |
Citation |
Score |
| 2020 |
Khan MA, Srivastava SK, Zubair H, Patel GK, Arora S, Khushman M, Carter JE, Gorman GS, Singh S, Singh AP. Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer. The Journal of Biological Chemistry. PMID 32358063 DOI: 10.1074/Jbc.Ra119.011748 |
0.365 |
|
| 2019 |
Khan MA, Patel GK, Srivastava SK, Arora S, Zubair H, Carter JE, Wang B, Singh S, Khushman M, Singh AP. Abstract 1911: Bi-directional cross-talk of pancreatic cancer and stellate cells, mediated through CXCR4 and hedgehog pathways, promotes chemoresistance via its effect on gemcitabine metabolism, ROS detoxification and cancer stemness Cancer Research. 79: 1911-1911. DOI: 10.1158/1538-7445.Sabcs18-1911 |
0.379 |
|
| 2016 |
Tyagi N, Srivastava SK, Arora S, Omar Y, Ijaz ZM, Al-Ghadhban A, Deshmukh SK, Carter JE, Singh AP, Singh S. Comparative analysis of the relative potential of silver, Zinc-oxide and titanium-dioxide nanoparticles against UVB-induced DNA damage for the prevention of skin carcinogenesis. Cancer Letters. PMID 27693632 DOI: 10.1016/J.Canlet.2016.09.026 |
0.31 |
|
| 2016 |
Averett C, Bhardwaj A, Arora S, Srivastava SK, Khan MA, Ahmad A, Singh S, Carter JE, Khushman M, Singh AP. Honokiol Suppresses Pancreatic Tumor Growth, Metastasis and Desmoplasia by Interfering with Tumor-Stromal Cross-Talk. Carcinogenesis. PMID 27609457 DOI: 10.1093/Carcin/Bgw096 |
0.352 |
|
| 2016 |
Bhardwaj A, Srivastava SK, Singh S, Tyagi N, Arora S, Carter JE, Khushman M, Singh AP. MYB promotes desmoplasia in pancreatic cancer through direct transcriptional upregulation and cooperative action of sonic hedgehog and adrenomedullin. The Journal of Biological Chemistry. PMID 27246849 DOI: 10.1074/Jbc.M116.732651 |
0.364 |
|
| 2016 |
Averett CA, Bhardwaj A, Arora S, Srivastava S, Singh S, Carter J, Singh AP. Abstract B02: Honokiol attenuates stemness, growth and metastasis of pancreatic tumor cells: A novel natural agent for therapy and prevention Cancer Research. 76. DOI: 10.1158/1538-7445.Fbcr15-B02 |
0.4 |
|
| 2016 |
Bhardwaj A, Srivastava SK, Tyagi N, Arora S, Singh S, Carter JE, Singh AP. Abstract 722: MYB promotes pancreatic tumor associated-desmoplasia by up-regulating Sonic hedgehog and adrenomedullin Cancer Research. 76: 722-722. DOI: 10.1158/1538-7445.Am2016-722 |
0.345 |
|
| 2016 |
Tyagi N, Arora S, Srivastava SK, Carter JE, Singh AP, Singh S. Abstract 5238: The chemopreventive potential of silver nanoparticles against UVB-induced skin carcinogenesis in mouse model Cancer Research. 76: 5238-5238. DOI: 10.1158/1538-7445.Am2016-5238 |
0.376 |
|
| 2016 |
Srivastava SK, Bhardwaj A, Singh S, Arora S, Tyagi N, Carter JE, Singh AP. Abstract 1988: MYB overexpression is associated with castration-resistance in prostate cancer Cancer Research. 76: 1988-1988. DOI: 10.1158/1538-7445.Am2016-1988 |
0.338 |
|
| 2015 |
Srivastava SK, Bhardwaj A, Arora S, Singh S, Azim S, Tyagi N, Carter JE, Wang B, Singh AP. MYB is a novel regulator of pancreatic tumour growth and metastasis. British Journal of Cancer. PMID 26657649 DOI: 10.1038/Bjc.2015.400 |
0.303 |
|
| 2015 |
Palanki R, Arora S, Tyagi N, Rusu L, Singh AP, Palanki S, Carter JE, Singh S. Size is an essential parameter in governing the UVB-protective efficacy of silver nanoparticles in human keratinocytes. Bmc Cancer. 15: 636. PMID 26373391 DOI: 10.1186/S12885-015-1644-8 |
0.357 |
|
| 2015 |
Tyagi N, Bhardwaj A, Srivastava SK, Arora S, Marimuthu S, Deshmukh SK, Singh AP, Carter JE, Singh S. Development and Characterization of a Novel in vitro Progression Model for UVB-Induced Skin Carcinogenesis. Scientific Reports. 5: 13894. PMID 26349906 DOI: 10.1038/Srep13894 |
0.372 |
|
| 2015 |
Srivastava SK, Bhardwaj A, Arora S, Tyagi N, Singh S, Andrews J, McClellan S, Wang B, Singh AP. MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways. British Journal of Cancer. 113. PMID 26247574 DOI: 10.1038/Bjc.2015.252 |
0.336 |
|
| 2015 |
Khan MA, Srivastava SK, Bhardwaj A, Singh S, Arora S, Zubair H, Carter JE, Singh AP. Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications. Oncotarget. PMID 25970774 DOI: 10.18632/Oncotarget.3784 |
0.38 |
|
| 2015 |
Srivastava SK, Bhardwaj A, Arora S, Tyagi N, Singh AP, Carter JE, Scammell JG, Fodstad Ø, Singh S. Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis. British Journal of Cancer. 112: 1772-81. PMID 25942396 DOI: 10.1038/Bjc.2015.154 |
0.343 |
|
| 2015 |
Arora S, Tyagi N, Bhardwaj A, Rusu L, Palanki R, Vig K, Singh SR, Singh AP, Palanki S, Miller ME, Carter JE, Singh S. Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 1265-75. PMID 25804413 DOI: 10.1016/J.Nano.2015.02.024 |
0.393 |
|
| 2015 |
Arora S, Tyagi N, Bhardwaj A, Rusu L, Palanki R, Singh AP, Carter JE, Singh S. Abstract 2811: Silver nanoparticles protect human keratinocytes from deleterious effects of ultraviolet radiation: Implications for skin cancer chemoprevention Cancer Research. 75: 2811-2811. DOI: 10.1158/1538-7445.Am2015-2811 |
0.422 |
|
| 2014 |
Averett C, Arora S, Zubair H, Singh S, Bhardwaj A, Singh AP. Molecular Targets of Honokiol: A Promising Phytochemical for Effective Cancer Management. The Enzymes. 36: 175-93. PMID 27102704 DOI: 10.1016/B978-0-12-802215-3.00009-4 |
0.314 |
|
| 2014 |
Bhardwaj A, Srivastava SK, Singh S, Arora S, Tyagi N, Andrews J, McClellan S, Carter JE, Singh AP. CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1. Oncotarget. 5: 11490-500. PMID 25359780 DOI: 10.18632/Oncotarget.2571 |
0.338 |
|
| 2014 |
Arora S, Swaminathan SK, Kirtane A, Srivastava SK, Bhardwaj A, Singh S, Panyam J, Singh AP. Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy. International Journal of Nanomedicine. 9: 2933-42. PMID 24971005 DOI: 10.2147/Ijn.S61949 |
0.329 |
|
| 2014 |
Srivastava SK, Arora S, Singh S, Bhardwaj A, Averett C, Singh AP. MicroRNAs in pancreatic malignancy: progress and promises. Cancer Letters. 347: 167-74. PMID 24561061 DOI: 10.1016/J.Canlet.2014.02.015 |
0.317 |
|
| 2014 |
Srivastava SK, Bhardwaj A, Arora S, Singh S, Grizzle WE, Singh AP. Abstract 3398: Reciprocal regulation ofMYBandCXCR4in pancreatic cancer cells: Potential pathobiological implications Cancer Research. 74: 3398-3398. DOI: 10.1158/1538-7445.Am2014-3398 |
0.39 |
|
| 2014 |
Tyagi N, Srivastava SK, Bhardwaj A, Arora S, Grizzle WE, Owen LB, Singh AP, Singh S. Abstract 2011: ETV4 promotes pancreatic cancer progression and metastasis Cancer Research. 74: 2011-2011. DOI: 10.1158/1538-7445.Am2014-2011 |
0.354 |
|
| 2014 |
Arora S, Swaminathan SK, Srivastava SK, Singh S, Panyam J, Singh AP. Abstract 1457: Development of miRNA-loaded polymeric nanoformulation for pancreatic cancer therapy Cancer Research. 74: 1457-1457. DOI: 10.1158/1538-7445.Am2014-1457 |
0.327 |
|
| 2013 |
Bhardwaj A, Arora S, Prajapati VK, Singh S, Singh AP. Cancer "stemness"- regulating microRNAs: role, mechanisms and therapeutic potential. Current Drug Targets. 14: 1175-84. PMID 23834145 DOI: 10.2174/13894501113149990190 |
0.328 |
|
| 2013 |
Arora S, Bhardwaj A, Singh S, Srivastava SK, McClellan S, Nirodi CS, Piazza GA, Grizzle WE, Owen LB, Singh AP. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4. The Journal of Biological Chemistry. 288: 21197-207. PMID 23740244 DOI: 10.1074/Jbc.M113.484576 |
0.322 |
|
| 2013 |
Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, et al. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. Plos One. 8: e58929. PMID 23554959 DOI: 10.1371/Journal.Pone.0058929 |
0.336 |
|
| 2013 |
Yamamura S, Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryary V, Arora S, Chang I, Tanaka Y, Carroll P, Dahiya R. Abstract 5340: MicroRNA-720 promotes cell proliferation and invasion in prostate cancer cells. Cancer Research. 73: 5340-5340. DOI: 10.1158/1538-7445.Am2013-5340 |
0.355 |
|
| 2013 |
Arora S, Bhardwaj A, Singh S, Srivastava SK, McClellan S, Grizzle WE, Owen LB, Singh AP. Abstract 4794: An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through upregulation of CXCR4. Cancer Research. 73: 4794-4794. DOI: 10.1158/1538-7445.Am2013-4794 |
0.376 |
|
| 2013 |
Bhardwaj A, Srivastava SK, Arora S, Hyde SJ, Andrews JF, McClellan S, Singh S, Singh AP. Abstract 4061: A novel CXCR4-mediated mechanism of docetaxel resistance in prostate cancer cells. Cancer Research. 73: 4061-4061. DOI: 10.1158/1538-7445.Am2013-4061 |
0.357 |
|
| 2013 |
Srivastava SK, Singh S, Bhardwaj A, Arora S, McClellan S, Grizzle WE, Singh AP. Abstract 3882: Myb contributes to pancreatic cancer growth and metastasis. Cancer Research. 73: 3882-3882. DOI: 10.1158/1538-7445.Am2013-3882 |
0.301 |
|
| 2013 |
Bhardwaj A, Singh S, Srivastava SK, Arora S, Hyde SJ, Honkanen RE, Grizzle WE, Singh AP. Abstract 3861: Downregulation of protein phosphatase 2A promotes prostate cancer progression and metastasis. Cancer Research. 73: 3861-3861. DOI: 10.1158/1538-7445.Am2013-3861 |
0.39 |
|
| 2013 |
Kaur G, Srivastava SK, Arora S, Bhardwaj A, McClellan S, Scammell JG, Grizzle WE, Owen LB, Fodstad O, Singh AP, Singh S. Abstract 2709: Functional Role of FKBP51 in malignant progression of melanoma. Cancer Research. 73: 2709-2709. DOI: 10.1158/1538-7445.Am2013-2709 |
0.39 |
|
| 2013 |
Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai Z, Enokida H, Seki N, Nakagawa M, et al. 327 GENISTEIN INHIBITS PROSTATE CANCER THROUGH ACTIVATION OF TUMOR SUPPRESSOR MICRORNA-574-3P Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1712 |
0.309 |
|
| 2012 |
Singh AP, Arora S, Bhardwaj A, Srivastava SK, Kadakia MP, Wang B, Grizzle WE, Owen LB, Singh S. CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase- and Akt kinase-mediated activation of nuclear factor κB: implications for bidirectional tumor-stromal interactions. The Journal of Biological Chemistry. 287: 39115-24. PMID 22995914 DOI: 10.1074/Jbc.M112.409581 |
0.372 |
|
| 2012 |
Arora S, Singh S, Piazza GA, Contreras CM, Panyam J, Singh AP. Honokiol: A novel natural agent for cancer prevention and therapy Current Molecular Medicine. 12: 1244-1252. PMID 22834827 DOI: 10.2174/156652412803833508 |
0.311 |
|
| 2012 |
Saini S, Majid S, Shahryari V, Arora S, Yamamura S, Chang I, Zaman MS, Deng G, Tanaka Y, Dahiya R. MiRNA-708 control of CD44+ prostate cancer-initiating cells Cancer Research. 72: 3618-3630. PMID 22552290 DOI: 10.1158/0008-5472.Can-12-0540 |
0.322 |
|
| 2012 |
Malhi SS, Budhiraja A, Arora S, Chaudhari KR, Nepali K, Kumar R, Sohi H, Murthy RSR. Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes International Journal of Pharmaceutics. 432: 63-74. PMID 22531856 DOI: 10.1016/J.Ijpharm.2012.04.030 |
0.36 |
|
| 2012 |
Srivastava SK, Bhardwaj A, Singh S, Arora S, McClellan S, Grizzle WE, Reed E, Singh AP. Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance. Carcinogenesis. 33: 1149-57. PMID 22431717 DOI: 10.1093/Carcin/Bgs134 |
0.36 |
|
| 2012 |
Arora S, Rajwade JM, Paknikar KM. Nanotoxicology and in vitro studies: the need of the hour. Toxicology and Applied Pharmacology. 258: 151-65. PMID 22178382 DOI: 10.1016/J.Taap.2011.11.010 |
0.588 |
|
| 2012 |
Srivastava SK, Bhardwaj A, Arora S, Singh S, McClellan S, Wang B, Grizzle WE, Singh AP. Abstract LB-468: miR-345 downregulation is associated with apoptosis resistance in pancreatic cancer: therapeutic implications Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-468 |
0.334 |
|
| 2012 |
Srivastava SK, Arora S, Bhardwaj A, Scammell JG, Owen LB, Grizzle WE, Singh AP, Singh S. Abstract 84: Evidence supporting a role of FKBP51 in melanoma pathogenesis Cancer Research. 72: 84-84. DOI: 10.1158/1538-7445.Am2012-84 |
0.386 |
|
| 2012 |
Bhardwaj A, Singh S, Srivastava SK, Arora S, Reed E, Singh AP. Abstract 605: Olive polyphenol, hydroxytyrosol, exerts anti-tumor effects in prostate cancer cells by targeting Akt, STAT3 and AR signaling Cancer Research. 72: 605-605. DOI: 10.1158/1538-7445.Am2012-605 |
0.374 |
|
| 2012 |
Bhardwaj A, Srivastava SK, Singh S, Arora S, Honkanen RE, Grizzle WE, Reed E, Singh AP. Abstract 3991: Protein phosphatase 2A (PP2A) downregulation is associated with androgen-independent and aggressive phenotypes in prostate cancer Cancer Research. 72: 3991-3991. DOI: 10.1158/1538-7445.Am2012-3991 |
0.392 |
|
| 2012 |
Arora S, Srivastava SK, Bhardwaj A, Singh AP, Piazza GA, Owen LB, Singh S. Abstract 1626: Honokiol inhibits IL-8 production and exerts anti-tumor effects in colon cancer cells: therapeutic and preventive implications Cancer Research. 72: 1626-1626. DOI: 10.1158/1538-7445.Am2012-1626 |
0.329 |
|
| 2011 |
Srivastava SK, Bhardwaj A, Singh S, Arora S, Wang B, Grizzle WE, Singh AP. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis. 32: 1832-9. PMID 21983127 DOI: 10.1093/Carcin/Bgr223 |
0.327 |
|
| 2011 |
Arora S, Bhardwaj A, Srivastava SK, Singh S, McClellan S, Wang B, Singh AP. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. Plos One. 6: e21573. PMID 21720559 DOI: 10.1371/Journal.Pone.0021573 |
0.396 |
|
| 2009 |
Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Molecular Pharmaceutics. 6: 1388-401. PMID 19473014 DOI: 10.1021/Mp900056G |
0.692 |
|
| 2009 |
Arora S, Jain J, Rajwade JM, Paknikar KM. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicology and Applied Pharmacology. 236: 310-8. PMID 19269301 DOI: 10.1016/J.Taap.2009.02.020 |
0.695 |
|
| 2008 |
Arora S, Jain J, Rajwade JM, Paknikar KM. Cellular responses induced by silver nanoparticles: In vitro studies. Toxicology Letters. 179: 93-100. PMID 18508209 DOI: 10.1016/J.Toxlet.2008.04.009 |
0.676 |
|
| 2007 |
Kale SN, Rajagopal R, Arora S, Bhayani KR, Rajwade JM, Paknikar KM, Kundaliya DC, Ogale SB. Microwave Response of La0.7Sr0.3MnO3 Nanoparticles for Heating Applications Journal of Biomedical Nanotechnology. 3: 178-183. DOI: 10.1166/Jbn.2007.021 |
0.617 |
|
| 2007 |
Bhayani KR, Kale SN, Arora S, Rajagopal R, Mamgain H, Kaul-Ghanekar R, Kundaliya DC, Kulkarni SD, Pasricha R, Dhole SD, Ogale SB, Paknikar KM. Protein and polymer immobilized La0.7Sr0.3MnO 3 nanoparticles for possible biomedical applications Nanotechnology. 18. DOI: 10.1088/0957-4484/18/34/345101 |
0.6 |
|
| 2006 |
Kale SN, Arora S, Bhayani KR, Paknikar KM, Jani M, Wagh UV, Kulkarni SD, Ogale SB. Cerium doping and stoichiometry control for biomedical use of La0.7Sr0.3MnO3 nanoparticles: microwave absorption and cytotoxicity study. Nanomedicine : Nanotechnology, Biology, and Medicine. 2: 217-21. PMID 17292146 DOI: 10.1016/J.Nano.2006.10.001 |
0.587 |
|
| Show low-probability matches. |